Prostatis Group’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.65M Buy
6,495
+3,687
+131% +$859K 0.38% 54
2026
Q1
$686K Buy
2,808
+45
+2% +$10.5K 0.18% 91
2025
Q4
$572K Buy
2,763
+1,476
+115% +$292K 0.14% 99
2025
Q3
$239K Buy
+1,287
New +$220K 0.06% 154
2024
Q1
Sell
-1,946
Closed -$305K 147
2023
Q4
$305K Buy
1,946
+138
+8% +$21.2K 0.13% 104
2023
Q3
$300K Sell
1,808
-53
-3% -$8.74K 0.15% 86
2023
Q2
$308K Sell
1,861
-3,899
-68% -$629K 0.14% 89
2023
Q1
$902K Sell
5,760
-183
-3% -$29.6K 0.48% 51
2022
Q4
$1.05M Buy
5,943
+4,250
+251% +$734K 0.64% 40
2022
Q3
$277K Sell
1,693
-26
-2% -$4.4K 0.32% 45
2022
Q2
$305K Buy
1,719
+278
+19% +$49.5K 0.48% 23
2022
Q1
$255K Sell
1,441
-153
-10% -$26K 0.2% 69
2021
Q4
$273K Sell
1,594
-4,874
-75% -$798K 0.17% 81
2021
Q3
$1.04M Buy
6,468
+295
+5% +$50.3K 0.62% 39
2021
Q2
$1.02M Buy
6,173
+952
+18% +$158K 0.69% 37
2021
Q1
$858K Buy
5,221
+853
+20% +$138K 0.67% 31
2020
Q4
$687K Buy
4,368
+917
+27% +$135K 0.58% 40
2020
Q3
$514K Buy
3,451
+871
+34% +$129K 0.49% 44
2020
Q2
$363K Buy
2,580
+935
+57% +$136K 0.73% 41
2020
Q1
$216K Sell
1,645
-61
-4% -$8.65K 0.31% 49
2019
Q4
$249K Buy
+1,706
New +$231K 0.22% 75

Other funds holding JNJ

Prostatis Group's JNJ Position: Q2 2026 in Review

Prostatis Group increased its Johnson & Johnson (JNJ) stake by 131% in Q2 2026, buying an estimated $859K and bringing the position to 6,495 shares worth $1.65M. The position accounts for 0.38% of the portfolio, ranked #54.

Prostatis Group first reported a position in JNJ in Q4 2019 and has held it in 21 quarters since. 4,676 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Prostatis Group held 6,495 shares of Johnson & Johnson worth $1.65M as of Q2 2026.
  • Prostatis Group bought 3,687 Johnson & Johnson shares in Q2 2026, an estimated $859K.
  • Johnson & Johnson made up 0.38% of Prostatis Group's portfolio in Q2 2026, its #54 holding.
  • Prostatis Group first reported a position in Johnson & Johnson in Q4 2019 and has held it in 21 quarters since.
  • 4,676 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Prostatis Group's 13F filing for Q2 2026, filed 14 Aug 2026.